The Health Science Authority or HSA is the Singaporean regulatory agency for health products. It is responsible for securing the national blood supply and providing scientific guidance on forensic science and medicine. It was formed on April 1st, 2001 by integrating five specialized Ministry of Health agencies: the Centre for Drug Evaluation; Institute of Science and Forensic Medicine; National Pharmaceutical Administration; Product Regulation Department; and Singapore Blood Transfusion Service.
The regulatory framework that ensures drugs, medical devices, and other health products are up to standards is enforced by the Health Products Regulation Group within the HSA. The group is responsible for pre-market approvals and clinical trials, as well as post-market surveillance activities.
The Health Products Regulation Group comprises the following divisions:
A list of HSA regulations can be found here on our website.
Contact details:
自2018年起,美国食品和药物管理局(U.S. Food and Drug Administration,FDA)开始试行以电子化方式来帮助行业提供完整的510(k)上市前通知。2022年,为推进以电子格式提供510(k)递交文件的过渡,美国FDA正式发布关于使用电子递交模板和资源的最终指导文
阅读更多您的公司为符合欧盟医疗器械法规(MDR)作了哪些准备? 在MDR规定下,医疗器械CE认证要求发生了重大变化,因此,医疗器械公司应当清楚地了解其合规程度,以及他们仍需采取哪些措施才能确保遵守新法规并维持欧盟市场准入资格。 我们的欧盟MDR准备情况检查表可以帮助您评估您
阅读更多